UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial

Journal of rheumatology, 2014-06, Vol.41 (6), p.1067-1076

2014

Volltextzugriff (PDF)

The effect of golimumab therapy on disease activity and health-related quality of life in patients with ankylosing spondylitis: 2-year results of the GO-RAISE trial

Journal of rheumatology, 2014-06, Vol.41 (6), p.1095-1103

2014

Volltextzugriff (PDF)

Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial

Journal of rheumatology, 2016-02, Vol.43 (2), p.298-306

2016

Volltextzugriff (PDF)

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate‐Naive Patients With Rheumatoid Arthritis: Five‐Year Results of a Randomized Clinical Trial

Arthritis care & research (2010), 2016-06, Vol.68 (6), p.744-752

2016

Volltextzugriff (PDF)

INVOLVING STUDENTS IN PROBLEM SOLVING

The Mathematics teacher, 1979-11, Vol.72 (8), p.617-622

GATHANY, TIMOTHY A.

1979

Volltextzugriff (PDF)

Involving Students in Problem Solving

Mathematics Teacher, 1979-11, Vol.72 (8), p.617

Gathany, Timothy A

1979

Volltextzugriff (PDF)

Involving Students in Problem Solving

The Mathematics teacher, 1979-11, Vol.72 (8), p.617-622

Gathany, Timothy A.

1979

Volltextzugriff (PDF)

Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years

Annals of the rheumatic diseases, 2011-09, Vol.70 (9), p.1631-1640

2011

Volltextzugriff (PDF)

Comparative Efficacy of Adalimumab, Golimumab, and Infliximab in the Treatment of Patients with Ulcerative Colitis: An Induction Analysis: 1707

The American journal of gastroenterology, 2013-10, Vol.108, p.S514

2013

Volltextzugriff (PDF)

Cost Per Clinical Remission and Clinical Response of Adalimumab, Golimumab, and Infliximab in the Treatment of Patients with Ulcerative Colitis: An Induction Analysis: 1712

The American journal of gastroenterology, 2013-10, Vol.108, p.S515-S516

2013

Volltextzugriff (PDF)

P-041 Cost per Clinical Response, Clinical Remission, and Mucosal Healing of Adalimumab, Golimumab, and Infliximab Among Patients with Ulcerative Colitis (UC)

Inflammatory bowel diseases, 2013-12, Vol.19, p.S41-S42

2013

Volltextzugriff (PDF)

P-060 Cost Per Clinical Response, Clinical Remission, and Mucosal Healing of Golimumab Among Patients with Ulcerative Colitis: Results from PURSUIT-Maintenance

Inflammatory bowel diseases, 2013-12, Vol.19, p.S52

2013

Volltextzugriff (PDF)

Effect of golimumab on patient-reported outcomes in rheumatoid arthritis: results from the GO-FORWARD study

Journal of rheumatology, 2012-06, Vol.39 (6), p.1185-1191

2012

Volltextzugriff (PDF)

Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis

Journal of rheumatology, 2007-07, Vol.34 (7), p.1465

2007

Volltextzugriff (PDF)

Early and Sustained Remission after Treatment with Subcutaneously Administered Golimumab Is Associated with Normalized Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Post-hoc Analysis from PURSUIT Induction and Maintenance Trials: 1721

The American journal of gastroenterology, 2013-10, Vol.108, p.S519

2013

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(6)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial

The effect of golimumab therapy on disease activity and health-related quality of life in patients with ankylosing spondylitis: 2-year results of the GO-RAISE trial

Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate‐Naive Patients With Rheumatoid Arthritis: Five‐Year Results of a Randomized Clinical Trial

INVOLVING STUDENTS IN PROBLEM SOLVING

Involving Students in Problem Solving

Involving Students in Problem Solving

Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years

Comparative Efficacy of Adalimumab, Golimumab, and Infliximab in the Treatment of Patients with Ulcerative Colitis: An Induction Analysis: 1707

Cost Per Clinical Remission and Clinical Response of Adalimumab, Golimumab, and Infliximab in the Treatment of Patients with Ulcerative Colitis: An Induction Analysis: 1712

P-041 Cost per Clinical Response, Clinical Remission, and Mucosal Healing of Adalimumab, Golimumab, and Infliximab Among Patients with Ulcerative Colitis (UC)

P-060 Cost Per Clinical Response, Clinical Remission, and Mucosal Healing of Golimumab Among Patients with Ulcerative Colitis: Results from PURSUIT-Maintenance

Effect of golimumab on patient-reported outcomes in rheumatoid arthritis: results from the GO-FORWARD study

Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis

Early and Sustained Remission after Treatment with Subcutaneously Administered Golimumab Is Associated with Normalized Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Post-hoc Analysis from PURSUIT Induction and Maintenance Trials: 1721

Suchergebnisse filtern